Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/2006
01/12/2006WO2006004173A1 Viral particle-like construct and method of forming the same under physiological conditions
01/12/2006WO2006003804A1 Oligonucleotide inhibiting tumor cell proliferation and method therefor
01/12/2006WO2006003463A1 Method for introducing a pna molecule conjugated to a positively charged peptide into the cytosol and/or the nucleus by photochemical internalisation (pci)
01/12/2006WO2006003412A1 Process for the removal of selectable marker gene sequences
01/12/2006WO2006003355A1 Purification of dna molecules
01/12/2006WO2006003298A2 Method of determining the mutational load of a gene library obtained by random mutagenesis of a particular gene and means for implementing same
01/12/2006WO2006003215A2 Targeted transgenesis of short hairpin rna expression cassettes using recombinase mediated cassette exchange
01/12/2006WO2006003018A2 Biologically safe transient protein expression in plants
01/12/2006WO2006003001A1 Generation of recombinant genes in bacteriophages
01/12/2006WO2006002547A1 A target-dependent nucleic acid adapter
01/12/2006WO2006002538A1 Immunostimulatory sirna molecules and uses therefor
01/12/2006WO2006002453A2 Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface
01/12/2006WO2005118821A3 Generation of plants with altered oil content
01/12/2006WO2005108564A3 Production of peptides in plants as viral coat protein fusion
01/12/2006WO2005103693A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
01/12/2006WO2005103295A3 Method and tools for analysis of nucleic acids
01/12/2006WO2005097207A3 Rna interference modulators of hedgehog signaling and uses thereof
01/12/2006WO2005090606A3 Identification of toxic nucleotide sequences
01/12/2006WO2005090573A3 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
01/12/2006WO2005085417A3 Bacterial system for protein transport in eukaryotic cells
01/12/2006WO2005075655A3 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use
01/12/2006WO2005074981A3 Inhibitors of tgf-r signaling for treatment of cns disorders
01/12/2006WO2005070023A3 Expression of apoa-1 and variants thereof using spliceosome mediated rna trans-splicing
01/12/2006WO2005058362A3 Method for opening tight junctions comprising the use of jam-1, claudin-4 and occludin protein antagonists as well as sirna molecules
01/12/2006WO2005049652A3 Methods of generating antibody diversity in vitro
01/12/2006WO2005047480A3 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast
01/12/2006WO2005045045A3 Recombinant microorganism
01/12/2006WO2005045039A3 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
01/12/2006WO2005033662A3 Foreign pas ligands regulate pas domain function
01/12/2006WO2005025495A3 Methods and compositions for blocking progression of a disease state
01/12/2006WO2005021718A3 Tubulin regulatory elements for use in plants
01/12/2006WO2005017128A3 Improved reagents for recombinogenic engineering and uses thereof
01/12/2006WO2005012486A3 Metabolically engineered bacterial strains having enhanced 2-keto-d-gluconate accumulation
01/12/2006WO2005009335A3 Live attenuated nidovirus vaccines
01/12/2006WO2005000007A3 Methods of making plants that exhibit enhanced disease resistance
01/12/2006WO2004090108A3 Irna conjugates
01/12/2006WO2004081184A3 Markerless transformation
01/12/2006WO2004078130A3 Posh interacting proteins and related methods
01/12/2006WO2004074431A3 Plant ion channels and related methods
01/12/2006WO2004071407A3 Antisense modulation of ptp1b expression
01/12/2006WO2004056974A3 Mutations affecting carotenoid production
01/12/2006WO2003089596A3 Novel prostate tumor-specific promoter
01/12/2006US20060010534 Inbred corn line PH8JR
01/12/2006US20060010520 Fertile transgenic corn plants
01/12/2006US20060010519 Method for producing ubiquinone-10 in plant
01/12/2006US20060010518 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
01/12/2006US20060010517 Regulation of gene expression in plants
01/12/2006US20060010516 Cell cycle genes and related methods
01/12/2006US20060010515 Transgenic plants expressing cytokinin biosynthetic genes and methods of use therefor
01/12/2006US20060010514 Polynucleotides encoding mature AHASL proteins for creating imidazolinone-tolerant plants
01/12/2006US20060010513 Oligonucleotide arrays to monitor gene expression and methods for making and using same
01/12/2006US20060010512 Nitrogen transport metabolism
01/12/2006US20060010511 Nobel glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthase and gene encoding it
01/12/2006US20060010506 Method for improving protein production
01/12/2006US20060009631 Nucleic acids encoding this enzyme; in humans, rodents; isotopes; purity; gene expression; transformation, translation of cells; sulfation of tyrosine; hybridization
01/12/2006US20060009527 Method of treating TRX mediated diseases
01/12/2006US20060009526 Method of treating TRX mediated diseases
01/12/2006US20060009429 Antiandrogen oligonucleotides usable for the treatment of dermatological androgen-related disorders relating to androgen metabolism, their pharmaceutical compositions, their uses and treatment method
01/12/2006US20060009412 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src
01/12/2006US20060009410 Effects of apolipoprotein B inhibition on gene expression profiles in animals
01/12/2006US20060009409 Double-stranded oligonucleotides
01/12/2006US20060009408 siRNA-Mediated gene silencing with viral vectors
01/12/2006US20060009406 Vectors having both isoforms of beta-hexosaminidase
01/12/2006US20060009405 Bispecific Oligonucleotide for the Treatment of CNS Malignancies
01/12/2006US20060009402 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes
01/12/2006US20060009383 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
01/12/2006US20060009380 Isolated deoxyribonucleic acid fragment that codes for the calcium binding proteins; treating skin disorders, like dry skin, hyperkeratosis, parakeratosis, psoriasis, ichthyosis, and neoplasia; cosmetics
01/12/2006US20060009361 Using compounds such as flufenpyr-ethyl, 2-[4-chloro-2-fluoro-5-(2-propynyloxy)phenyl]-4-methy-5-(trifluoromethyl)-3(2H)-pyridazinone,carfentrazone-ethyl, sulfentrazone;to a cultivation area of a plant that expresses an introduced DNA encoding cytochrome P450
01/12/2006US20060008911 Methods and compositions for regulating gene expression in plant cells
01/12/2006US20060008910 stable nucleic acid-lipid particles (SNALP)
01/12/2006US20060008909 contains phospholipid and cholesterol, MnSO4 or MgSO4 within, and anticancer agent such as vinca alkaloids; increased retention; leukemia, lymphoma
01/12/2006US20060008908 Method and composition for longevity assurance
01/12/2006US20060008907 Control of gene expression via light activated RNA interference
01/12/2006US20060008906 Electrofusionof cells and apparatus therefore
01/12/2006US20060008900 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the PEDF gene
01/12/2006US20060008894 Yeast model for amyloidogenic protein toxicity
01/12/2006US20060008889 Phosphatase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, autoimmune, muscular and graft vs. host diseases
01/12/2006US20060008884 Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof
01/12/2006US20060008882 Antibody or fragment that specifically binds to CK alpha -5 polypeptides; may be chimeric antibody or fragment thereof, a single chain antibody, a Fab fragment, or a F(ab')2 fragment; Western blot or an enzyme-linked immunosorbent assay; hybridoma that produces the antibody
01/12/2006US20060008877 Expression systems with sec-system secretion
01/12/2006US20060008873 Cloning and sequencing of allergens of dermatophagoides (house dust mite)
01/12/2006US20060008872 substitutes valine for phenylalanine residue in an alpha -helix domain participating in the binding of a human cytokine protein to a corresponding receptor
01/12/2006US20060008871 Extract of E. coli cells having mutation in ribosomal protein S12, and method for producing protein in cell-free system using the extract
01/12/2006US20060008869 Process for production of biopterin compound
01/12/2006US20060008857 Cap-binding protein
01/12/2006US20060008855 Promiscuous G-protein compositions and their use
01/12/2006US20060008853 Monoclonal antibodies directed against the microtubule-associated protein tau and method of detecting the same
01/12/2006US20060008852 Marine actinomycete taxon for drug and fermentation product discovery
01/12/2006US20060008841 Aptamer capable of specifically adsorbing to verotoxin-1 and method for obtaining the aptamer
01/12/2006US20060008837 Compositions and methods for detecting estrogenic agents in a sample
01/12/2006US20060008835 PNA monomer and precursor
01/12/2006US20060008822 Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety
01/12/2006US20060008820 Cell cycle genes in plants
01/12/2006US20060008816 Promoter, Promoter control elements, and combinations, and uses thereof
01/12/2006US20060008804 Marker genes
01/12/2006US20060008802 Method for the identification of inhibitors of the binding of are-containing mrna and a hur protein
01/12/2006US20060008794 HOX code functions as a growth synchronizing moving reference frame
01/12/2006US20060008474 Polypeptides containing polymorphisms of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions
01/12/2006US20060008471 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
01/12/2006US20060008470 Use of vaccinia virus deleted for the E3L gene as a vaccine vector